Indian Companies Should Follow Teva Path, With Market-specific Plans, Global Scale – Experts
This article was originally published in PharmAsia News
Executive Summary
Rapid global expansion with control on costs may keep Indian drug companies in business. The larger the size the better, say experts from IMS Health and Accenture.